{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T01:50:26Z","timestamp":1791078626497,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,20]],"date-time":"2013-07-20T00:00:00Z","timestamp":1374278400000},"content-version":"vor","delay-in-days":231,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.celrep.2012.11.001","type":"journal-article","created":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T15:22:10Z","timestamp":1354202530000},"page":"1492-1497","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":187,"title":["The Sirtuin 2 Inhibitor AK-7 Is Neuroprotective in Huntington\u2019s Disease Mouse Models"],"prefix":"10.1016","volume":"2","author":[{"given":"Vanita","family":"Chopra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Quinti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine","family":"Vollor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.\u00a0Lakshmi","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Edgerly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia\u00a0M.","family":"Cipicchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly\u00a0A.","family":"Lauver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo\u00a0Hyuk","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard\u00a0B.","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert\u00a0J.","family":"Ferrante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Hersch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksey\u00a0G.","family":"Kazantsev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2012.11.001_bib1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2012.11.001_bib2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/bfgp\/elm008","article-title":"Appearances can be deceiving: phenotypes of knockout mice","volume":"6","author":"Barbaric","year":"2007","journal-title":"Brief. Funct. Genomics Proteomics"},{"key":"10.1016\/j.celrep.2012.11.001_bib3","doi-asserted-by":"crossref","first-page":"E952","DOI":"10.1073\/pnas.1104969108","article-title":"Sir-two-homolog 2 (Sirt2) modulates peripheral myelination through polarity protein Par-3\/atypical protein kinase C (aPKC) signaling","volume":"108","author":"Beirowski","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2012.11.001_bib4","doi-asserted-by":"crossref","first-page":"e34805","DOI":"10.1371\/journal.pone.0034805","article-title":"SIRT2 ablation has no effect on tubulin acetylation in brain, cholesterol biosynthesis or the progression of Huntington\u2019s disease phenotypes in\u00a0vivo","volume":"7","author":"Bobrowska","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.celrep.2012.11.001_bib5","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1016\/j.bmcl.2012.02.089","article-title":"3-(N-arylsulfamoyl)benzamides, inhibitors of human sirtuin type 2 (SIRT2)","volume":"22","author":"Choi","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.celrep.2012.11.001_bib6","doi-asserted-by":"crossref","first-page":"16685","DOI":"10.1073\/pnas.0707842104","article-title":"A small-molecule therapeutic lead for Huntington\u2019s disease: preclinical pharmacology and efficacy of C2-8 in the R6\/2 transgenic mouse","volume":"104","author":"Chopra","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2012.11.001_bib7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1474-9726.2010.00548.x","article-title":"Aging and disease: connections to sirtuins","volume":"9","author":"Donmez","year":"2010","journal-title":"Aging Cell"},{"key":"10.1016\/j.celrep.2012.11.001_bib8","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.nurt.2008.01.003","article-title":"Neuroprotection for Huntington\u2019s disease: ready, set, slow","volume":"5","author":"Hersch","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.celrep.2012.11.001_bib9","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/jmcb\/mjr009","article-title":"Sirt2 is a novel in\u00a0vivo downstream target of Nkx2.2 and enhances oligodendroglial cell differentiation","volume":"3","author":"Ji","year":"2011","journal-title":"J.\u00a0Mol. Cell. Biol."},{"key":"10.1016\/j.celrep.2012.11.001_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/dds379","article-title":"Selective histone deacetylase (HDAC) inhibition imparts beneficial effects in Huntington\u2019s disease mice: implications for the ubiquitin-proteasomal and autophagy systems","author":"Jia","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.celrep.2012.11.001_bib11","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.nbd.2012.01.016","article-title":"Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington\u2019s disease","volume":"46","author":"Jia","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.celrep.2012.11.001_bib12","doi-asserted-by":"crossref","first-page":"7927","DOI":"10.1073\/pnas.1002924107","article-title":"SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis","volume":"107","author":"Luthi-Carter","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2012.11.001_bib13","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1093\/hmg\/ddr326","article-title":"The Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNS","volume":"20","author":"Maxwell","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.celrep.2012.11.001_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/cne.10776","article-title":"Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington\u2019s disease with 140 CAG repeats","volume":"465","author":"Menalled","year":"2003","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.celrep.2012.11.001_bib15","doi-asserted-by":"crossref","first-page":"RRN1205","DOI":"10.1371\/currents.RRN1205","article-title":"Optimization of an HTRF Assay for the Detection of Soluble Mutant Huntingtin in Human Buffy Coats: A Potential Biomarker in Blood for Huntington Disease","volume":"2","author":"Moscovitch-Lopatin","year":"2010","journal-title":"PLoS Curr."},{"key":"10.1016\/j.celrep.2012.11.001_bib16","doi-asserted-by":"crossref","first-page":"e31080","DOI":"10.1371\/journal.pone.0031080","article-title":"Genetic knock-down of HDAC3 does not modify disease-related phenotypes in a mouse model of Huntington\u2019s disease","volume":"7","author":"Moumn\u00e9","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.celrep.2012.11.001_bib17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1097-2765(03)00038-8","article-title":"The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase","volume":"11","author":"North","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2012.11.001_bib18","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1126\/science.1143780","article-title":"Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson\u2019s disease","volume":"317","author":"Outeiro","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.celrep.2012.11.001_bib19","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1093\/hmg\/ddn273","article-title":"Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington\u2019s disease","volume":"17","author":"Pallos","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.celrep.2012.11.001_bib20","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/brain\/awn025","article-title":"Cerebral cortex and the clinical expression of Huntington\u2019s disease: complexity and heterogeneity","volume":"131","author":"Rosas","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.celrep.2012.11.001_bib21","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/cne.20680","article-title":"Chronology of behavioral symptoms and neuropathological sequela in R6\/2 Huntington\u2019s disease transgenic mice","volume":"490","author":"Stack","year":"2005","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.celrep.2012.11.001_bib22","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1021\/cb100376q","article-title":"A brain-permeable small molecule reduces neuronal cholesterol by inhibiting activity of sirtuin 2 deacetylase","volume":"6","author":"Taylor","year":"2011","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.celrep.2012.11.001_bib23","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1111\/j.1742-4658.2008.06561.x","article-title":"Huntington\u2019s disease: revisiting the aggregation hypothesis in polyglutamine neurodegenerative diseases","volume":"275","author":"Truant","year":"2008","journal-title":"FEBS J."},{"key":"10.1016\/j.celrep.2012.11.001_bib24","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1101\/gad.1412706","article-title":"SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis","volume":"20","author":"Vaquero","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.celrep.2012.11.001_bib25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1172\/JCI17742","article-title":"Huntingtin in health and disease","volume":"111","author":"Young","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.celrep.2012.11.001_bib26","doi-asserted-by":"crossref","unstructured":"Pandithage, R., Lilischkis, R., Harting, K., Wolf, A., Jedamzik, B., L\u00fcscher-Firzlaff, J., Vervoorts, J., Lasonder, E., Kremmer, E., Kn\u00f6ll, B., and L\u00fcscher, B. (2008). The regulation of SIRT2 function by cyclin-dependent kinases affects cell motility. J. Cell Biol. 180, 915\u2013929.","DOI":"10.1083\/jcb.200707126"}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124712003828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124712003828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:19:43Z","timestamp":1761902383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124712003828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S2211124712003828"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2012.11.001","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Sirtuin 2 Inhibitor AK-7 Is Neuroprotective in Huntington\u2019s Disease Mouse Models","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2012.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}